Search research articles
Contact Us
Filters
Showing results (171-180 of 183) with videos related to
Page
of 19
Sort By:
Prehospital Emergency Care
|
June 16, 2026
Internationally Informed Consensus on Research Priorities in Paramedicine and Emergency Medical Services (EMS)
Brett Williams, Christine King, Richard Armour, et al.
Resuscitation
|
October 21, 2025
Education, Implementation, and Teams: 2025 International Liaison Committee on Resuscitation Consensus on Science With Treatment Recommendations
Robert Greif, Adam Cheng, Cristian Abelairas-Gómez, et al.
Circulation
|
October 22, 2025
Education, Implementation, and Teams: 2025 International Liaison Committee on Resuscitation Consensus on Science With Treatment Recommendations
Robert Greif, Adam Cheng, Cristian Abelairas-Gómez, et al.
Cancer Research
|
April 5, 2013
Cisplatin resistance associated with PARP hyperactivation
Judith Michels, Ilio Vitale, Lorenzo Galluzzi, et al.
The Journal of Clinical Investigation
|
February 16, 2018
DNA repair deficiency sensitizes lung cancer cells to NAD+ biosynthesis blockade
Mehdi Touat, Tony Sourisseau, Nicolas Dorvault, et al.
The New England Journal of Medicine
|
March 22, 2013
ERCC1 isoform expression and DNA repair in non-small-cell lung cancer
Luc Friboulet, Ken André Olaussen, Jean-Pierre Pignon, et al.
Molecular Cancer
|
October 4, 2024
Deciphering resistance mechanisms in cancer: final report of MATCH-R study with a focus on molecular drivers and PDX development
Damien Vasseur, Ludovic Bigot, Kristi Beshiri, et al.
NPJ Precision Oncology
|
September 23, 2020
Feasibility and first reports of the MATCH-R repeated biopsy trial at Gustave Roussy
Gonzalo Recondo, Linda Mahjoubi, Aline Maillard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2026
Recurrent resistance mutations to lirafugratinib inform treatment sequencing in FGFR2-driven tumors
Francesco Facchinetti, Antoine Hollebecque, Rémy Barbé, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2019
Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer
Gonzalo Recondo, Laura Mezquita, Francesco Facchinetti, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 183) with videos related to
Sort By:
Page
of 19
Prehospital Emergency Care
|
June 16, 2026
Internationally Informed Consensus on Research Priorities in Paramedicine and Emergency Medical Services (EMS)
Brett Williams, Christine King, Richard Armour, et al.
Resuscitation
|
October 21, 2025
Education, Implementation, and Teams: 2025 International Liaison Committee on Resuscitation Consensus on Science With Treatment Recommendations
Robert Greif, Adam Cheng, Cristian Abelairas-Gómez, et al.
Circulation
|
October 22, 2025
Education, Implementation, and Teams: 2025 International Liaison Committee on Resuscitation Consensus on Science With Treatment Recommendations
Robert Greif, Adam Cheng, Cristian Abelairas-Gómez, et al.
Cancer Research
|
April 5, 2013
Cisplatin resistance associated with PARP hyperactivation
Judith Michels, Ilio Vitale, Lorenzo Galluzzi, et al.
The Journal of Clinical Investigation
|
February 16, 2018
DNA repair deficiency sensitizes lung cancer cells to NAD+ biosynthesis blockade
Mehdi Touat, Tony Sourisseau, Nicolas Dorvault, et al.
The New England Journal of Medicine
|
March 22, 2013
ERCC1 isoform expression and DNA repair in non-small-cell lung cancer
Luc Friboulet, Ken André Olaussen, Jean-Pierre Pignon, et al.
Molecular Cancer
|
October 4, 2024
Deciphering resistance mechanisms in cancer: final report of MATCH-R study with a focus on molecular drivers and PDX development
Damien Vasseur, Ludovic Bigot, Kristi Beshiri, et al.
NPJ Precision Oncology
|
September 23, 2020
Feasibility and first reports of the MATCH-R repeated biopsy trial at Gustave Roussy
Gonzalo Recondo, Linda Mahjoubi, Aline Maillard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2026
Recurrent resistance mutations to lirafugratinib inform treatment sequencing in FGFR2-driven tumors
Francesco Facchinetti, Antoine Hollebecque, Rémy Barbé, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2019
Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer
Gonzalo Recondo, Laura Mezquita, Francesco Facchinetti, et al.
Page
of 19